SanBio Co., Ltd.

As of July 31, 2026, SanBio Co., Ltd. carries a market capitalization of 71.74B, placing it among publicly traded companies globally. Its enterprise value stands at 60.11B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

SanBio Co., Ltd.'s next confirmed earnings release is scheduled for December 10, 2026.

As of July 31, 2026, SanBio Co., Ltd. has 78.06M shares outstanding.

These figures are as of July 31, 2026.

As of July 31, 2026, SanBio Co., Ltd. maintains a current ratio of 39.40, meaning it holds 39.4x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended July 31, 2026.

As of the close on October 22, 2026, SanBio Co., Ltd.'s stock has declined approximately 69.09% over the past 52 weeks. The 50-day moving average sits at 963.06, while the 200-day moving average is 1,474.13.

As of July 31, 2026, SanBio Co., Ltd. holds 12.75B in cash and equivalents against 1.13B in total debt, resulting in a net debt position of -11.62B. Total book value stands at 11.72B, with working capital of 13.04B providing operational flexibility.